Work

Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease

Year: 2021

Type: article

Source: Blood Cells Molecules and Diseases

DOI: 10.1016/j.bcmd.2021.102561

Authors: Betty S. Pace, Susan Perrine, Biaoru Li, Levi Makala, Hongyan Xu, Mayuko Takezaki, Roman F. Wolf, Amy Wang, Xin Xu, Junfeng Huang, Asaf Alimardanov, Gregory J. Tawa, Jose Sangerman, Aidan Faller, Wei Zheng, London Toney, Sharie J. Haugabook

Institutions: Augusta University, Boston University, Phoenicia Biosciences (United States), University of Oklahoma Health Sciences Center, National Institutes of Health, National Center for Advancing Translational Sciences

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: School of Medicine, Boston University, National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: G386607036, G5888954722, Development of a clinical hemoglobin modulator, Novel Globin Gene Modulators, Repurposing an EU Therapeutic for Hemoglobinopathies

OpenAlex ID: W3138399121

FWCI: 2.28

Cites: 57

Cited by: 17

Related to: 10